This episode explores the risks and consequences of cold chain failures, especially for
advanced therapies such as cell and gene treatments. We'll talk about how these
therapies are impacted by shipment disruptions and the importance of early cold chain
planning. The conversation will also touch on collaboration with CDMOs and logistics
providers, as well as broader reflections on where the industry needs to improve.
","author_name":"YSDS"}